Literature DB >> 18240881

Review of the NAEPP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines.

Frank L Urbano1.   

Abstract

BACKGROUND: In 1989, the National Asthma Education and Prevention Program (NAEPP) convened an expert panel to develop a report that would provide a general approach to the treatment of asthma. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma, or EPR-1, was published in 1991 and was subsequently updated with 2 other reports, EPR-2 in 1997 and the EPR update in 2002. Advances in science and a greater understanding of the pathophysiology of asthma prompted the NAEPP to convene a 3rd expert panel in 2004. After nearly 3 years of work, Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma-Full Report 2007, or EPR-3, was released on August 29, 2007. EPR-3 update from the NAEPP provides health care professionals with new information to improve the care of patients with asthma, including (1) more comprehensive discussion of asthma severity with expanded descriptions of impairment and risk, (2) increased focus on asthma control as a goal of therapy, and (3) expanded discussion of pharmacologic therapy for asthma with updated treatment algorithms.
OBJECTIVES: To (1) extract key educational messages from the EPR-3 update that effectively summarize the appropriate management of the patient with asthma and (2) provide supporting literature to substantiate the development of these educational messages.
METHODS: A consensus meeting of 9 asthma experts (4 pharmacists and 5 physicians) was held to discuss the EPR-3 update and condense its content into a usable format for the health care professional. Experts were selected on the basis of several criteria, including (1) affiliation with the NAEPP, (2) expertise in asthma management, and (3) familiarity with managed care processes. The author served as the 10th member and moderator of the meeting.
RESULTS: Thorough review of the EPR-3 update resulted in the development of 7 key educational messages that can assist the health care professional in improving the management of the patient with asthma. Each educational message is presented with supporting literature to substantiate its distinction as a key point to be referenced when developing protocols for asthma management within managed care organizations.
CONCLUSION: The complexity of asthma and its treatment has necessitated the development of several guidelines from the NAEPP, with the most recent EPR-3 update being released in late August 2007. One expert consensus has distilled the EPR-3 document into 7 key educational messages that can assist the health care professional in improving the care of the patient with asthma.

Entities:  

Mesh:

Year:  2008        PMID: 18240881     DOI: 10.18553/jmcp.2008.14.1.41

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


  18 in total

1.  Real-World Assessment of Asthma Control and Severity in Children, Adolescents, and Adults with Asthma: Relationships to Care Settings and Comorbidities.

Authors:  Sharmilee M Nyenhuis; Esra Akkoyun; Li Liu; Michael Schatz; Thomas B Casale
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-07

2.  Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.

Authors:  Krisztian Nemeth; Andrea Keane-Myers; Jared M Brown; Dean D Metcalfe; James D Gorham; Jared D Gorham; Virgilio G Bundoc; Victor G Bundoc; Marcus G Hodges; Ivett Jelinek; Satish Madala; Sarolta Karpati; Eva Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

3.  The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma.

Authors:  Anupam B Jena; Oliver Ho; Dana P Goldman; Pinar Karaca-Mandic
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

4.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

Review 5.  Asthma and pregnancy.

Authors:  Rani Reddy Vatti; Suzanne S Teuber
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

6.  How Do Perceptions of Asthma Control and Severity Relate to Indicators of Asthma Status and Treatment Recommendations by Pediatricians?

Authors:  Seifu Demissie; Kristin A Riekert; Michelle N Eakin; Andrew Bilderback; Gregory B Diette; Sande O Okelo
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2012-03       Impact factor: 1.349

7.  Inhaled corticosteroid beliefs, complementary and alternative medicine, and uncontrolled asthma in urban minority adults.

Authors:  Maureen George; Maxim Topaz; Cynthia Rand; Marilyn Lynn Sawyer Sommers; Karen Glanz; Michael V Pantalon; Jun J Mao; Judy A Shea
Journal:  J Allergy Clin Immunol       Date:  2014-09-11       Impact factor: 10.793

8.  Changes in clinical conversations when providers are informed of asthma patients' beliefs about medication use and integrative medical therapies.

Authors:  Maureen George; Sarah Abboud; Michael V Pantalon; Marilyn Lynn S Sommers; Jun Mao; Cynthia Rand
Journal:  Heart Lung       Date:  2016 Jan-Feb       Impact factor: 2.210

9.  Collection of aerosolized human cytokines using Teflon® filters.

Authors:  Jennifer H McKenzie; James J McDevitt; M Patricia Fabian; Grace M Hwang; Donald K Milton
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  Genetics of asthma: a molecular biologist perspective.

Authors:  Amrendra Kumar; Balaram Ghosh
Journal:  Clin Mol Allergy       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.